News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge-Based SAGE Therapeutics Readies $69 Million IPO Pitch To Develop CNS Drugs


6/18/2014 6:59:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sage Therapeutics made it pretty clear it was plotting an IPO when it added a group of public investment funds to its latest private financing round a few months ago. The Cambridge, MA-based company followed through today, filing papers outlining plans to tap Wall Street to develop drugs for rare neurological disorders.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy
Read at Nasdaq

comments powered by Disqus
Xconomy
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES